Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation study - Smits, M L; Nijsen, J F; van den Bosch, M A (Lancet Oncol, 2012)
et al.